BS
MRNA icon

Banco Santander’s Moderna MRNA Stock Holding History

Banco Santander’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.07M Sell
86,677
-46,352
-35% -$2.4M 0.04% 202
2026
Q1 		$6.76M Sell
133,029
-74,120
-36% -$3.46M 0.05% 184
2025
Q4 		$6.11M Sell
207,149
-8,745
-4% -$238K 0.05% 183
2025
Q3 		$5.58M Buy
215,894
+39,056
+22% +$1.09M 0.05% 188
2025
Q2 		$4.88M Buy
176,838
+27,731
+19% +$730K 0.05% 204
2025
Q1 		$4.23M Buy
149,107
+43,296
+41% +$1.54M 0.05% 208
2024
Q4 		$4.4M Buy
105,811
+52,696
+99% +$2.52M 0.05% 182
2024
Q3 		$3.55M Buy
+53,115
New +$4.88M 0.04% 203
2023
Q2 		– Sell
-7,291
Closed -$1.12M – 425
2023
Q1 		$1.12M Sell
7,291
-2,624
-26% -$433K 0.02% 213
2022
Q4 		$1.78M Sell
9,915
-2,825
-22% -$462K 0.03% 186
2022
Q3 		$1.51M Sell
12,740
-34
-0.3% -$5.16K 0.02% 210
2022
Q2 		$1.82M Sell
12,774
-4,397
-26% -$628K 0.02% 221
2022
Q1 		$2.96M Sell
17,171
-6,617
-28% -$1.11M 0.03% 209
2021
Q4 		$6.04M Buy
23,788
+11,435
+93% +$3.34M 0.03% 152
2021
Q3 		$4.75M Sell
12,353
-10,533
-46% -$3.88M 0.03% 169
2021
Q2 		$5.38M Buy
+22,886
New +$4.09M 0.03% 158

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Banco Santander's MRNA Position: Q2 2026 in Review

Banco Santander reduced its Moderna (MRNA) stake by 35% in Q2 2026, selling an estimated $2.4M and leaving 86,677 shares worth $6.07M. The position accounts for 0.04% of the portfolio, ranked #202.

Banco Santander first reported a position in MRNA in Q2 2021 and has held it in 16 quarters since. The position peaked at $6.76M in Q1 2026. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Banco Santander held 86,677 shares of Moderna worth $6.07M as of Q2 2026.
  • Banco Santander sold 46,352 Moderna shares in Q2 2026, an estimated $2.4M.
  • Moderna made up 0.04% of Banco Santander's portfolio in Q2 2026, its #202 holding.
  • Banco Santander first reported a position in Moderna in Q2 2021 and has held it in 16 quarters since.
  • Banco Santander's Moderna position peaked at $6.76M in Q1 2026.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.